GLP-1 medications are recommended in the ADA Standards of Care for those with cardiovascular disease, heart failure, and/or kidney disease to reduce the risk of adverse events due to these conditions
Additionally, there was a noted possible reduction in the activity of myeloperoxidase (MPO), an enzyme that serves as a marker for neutrophil-driven inflammation and oxidative stress, in lung tissues that received GHK-Cu exposure
In another experiment, ezetimibe + simvastatin 10 mg/day prevented a reduction in FMD after a high-fat meal better than simvastatin 80 mg/day alone
Functional enrichment analysis was performed with DAVID using the pathways related to metabolism from the KEGG database annotation
compounding regulations
Potential Drawbacks or Limitations: Gastrointestinal Side Effects: Common side effects include nausea, vomiting, and diarrhea